Navigation Links
GAO Confirms Payment Delays to Medical Equipment Providers; Questions Arise as to Whether Medicare Can Implement Reforms
Date:5/18/2010

Legitimate Medical Equipment Providers Are Victimized by Administrative Backlogs

WASHINGTON, May 18 /PRNewswire-USNewswire/ -- A recent study by the Government Accountability Office (GAO) confirms that the processing of Medicare reimbursement claims for medical equipment providers continues to be a problem despite the government's efforts to implement reforms.  The administrative shortcomings within the Medicare program have caused painful payment delays and other problems affecting medical equipment providers.

Durable Medical Equipment providers, such as those supplying power wheelchairs and oxygen, have been victims of the Medicare system's questionable management. They are burdened by excessive audits, claim denials that are routinely overturned after time-consuming appeals, and documentation guidelines that often contradict previous policies. While the Centers for Medicare and Medicaid Services (CMS) cite cracking down on fraud as a rationale for some of these procedures, the way they have been implemented has harmed legitimate equipment providers.    

"The homecare community applauds efforts to root out Medicare fraud," said Tyler Wilson, president of the American Association for Homecare (AAHomecare). "But Medicare beneficiaries and those who provide them with vital medical equipment deserve a more efficient administrative process, one that does not create major obstacles for legitimate businesses that are serving some of the most vulnerable people in our society.  This is wrong, and Congress and the administration should put an end to it."

Wilson noted that the GAO report, "Medicare Contracting Reform" (GAO-10-71, March 2010,

SOURCE American Association for Homecare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Watson Confirms EVISTA(R) Patent Challenge
2. Watson Confirms Trilipix(R) Patent Challenge
3. Watson Confirms Rapamune(R) Patent Challenge
4. Watson Confirms Cenestin(R) Patent Challenge
5. Watson Confirms Filing of Generic Opana(R) ER Application
6. NASDAQ Stock Market Confirms WorldHearts Compliance With NASDAQ Listing Rule 5605
7. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
8. Lilly Confirms Date and Conference Call For Fourth-Quarter and Full-Year 2009 Financial Results Announcement
9. HHS Report Confirms that the Complicated Medicare Documentation Requirements for Power Wheelchair Claims Obstruct Regulatory Compliance by Physicians and Wheelchair Providers
10. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015  The findings of ... raising disturbing questions about the company,s handling of its ... reports.  On September 2 nd , part one ... adverse events, including at least 27 fatalities, have been ... a confidential study commissioned by C.R. Bard in 2004 ...
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/4q3mv2/investigation ) ... on China Olmesartan Market, 2010-2019" report to their ... successfully developed by Sankyo Pharmaceuticals Co., Ltd and was ... was approved by FDA to enter the American market ... drug in the world after it succeeded in the ...
(Date:9/3/2015)... Sept. 3, 2015 Research and Markets ... the "Investigation Report on China Tamsulosin Market, ... Compared with other a1- adrenergic receptor blockers, ... and lower risk of urinary tract infections and ... its debut in 1993 in Japan ...
Breaking Medicine Technology:IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3China Olmesartan Investigation Market Report 2010-2019 2China Tamsulosin Market Investigation Report 2015 2
... 2010 ViroPharma Incorporated (Nasdaq: VPHM ) ... Cinryze ® (C1 esterase inhibitor [human]) at the ... (WAO), December 5 through 8 in Dubai, UAE.   ... these data, which were first presented at the November ...
... Healthcare, a world-leading developer, manufacturer and marketer of innovative ... that in connection with a refinancing of its debt ... in combination with new senior secured credit facilities, it ... Senior Notes. The offering of the new notes will ...
Cached Medicine Technology:Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 2Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 3Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 4Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 5Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 6Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 7Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 8Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 9ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering 2ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering 3
(Date:9/3/2015)... ... September 03, 2015 , ... TransPack Toon gives users a set of 90 ... and framing transitions in 30 different styles. Presets range from snow, underwater, forest, futuristic, ... , TransPack Toon features 90 cartoon transitions from 30 unique styles. Editors can ...
(Date:9/3/2015)... ... 03, 2015 , ... The Beryl Institute announces 52 breakout ... held April 13-15 at Sheraton Hotel in Dallas, Texas. Patient Experience Conference is ... of healthcare leaders, staff, physicians, patients and families across the globe to convene, ...
(Date:9/3/2015)... ... September 03, 2015 , ... Results of ... for Healthcare Research and Policy Analysis has found physician leadership development training programs ... 47 percent of respondents said their organizations conduct some kind of physician leadership ...
(Date:9/3/2015)... ... September 03, 2015 , ... For many ... garments. However, graduated compression garments are an effective solution for reducing the medical ... Bjork, was recently sponsored by SIGVARIS for a unique opportunity to ...
(Date:9/3/2015)... ... ... Girl’s Night Out to benefit Core Compassion Project will be held on ... Monroe, North Carolina. The event food will be provided by Kate Clyde's ... off-premise catering and event services from casual to elegant. They are also the home ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2
... ... become an Infor channel partner. Through the partnership, ZSL will provide implementation services and ... ... been deployed by manufacturing companies around the world to help them manage and run their ...
... health workers gauge patient,s state of mind, researchers say ... used psychological test has the potential to gauge how ... insight into what their patients are thinking, a new ... to show whether people automatically associate things with each ...
... loss conditions, experts say, , WEDNESDAY, April 14 (HealthDay ... gene to a rare condition that makes people develop ... greater insight into male-pattern baldness. , The finding won,t ... Angela M. Christiano, co-author of the study, published April ...
... ... , ... April 14, 2010 -- McGraw-Hill, the global leader in business books for professionals, has signed ... Tim Riesterer, CMO and SVP of Consulting and Products and Erik Peterson, VP of ...
... They were illiterate farmers, builders and servants, but Maya commoners ... burying it within their homes. A new study of the ... 1,000 years ago in central Belize begins to decode their ... Lisa J. Lucero, appears in the Journal of Social ...
... the Sackler Center at Weill Cornell Medical College have designed a ... responsible for causing the most common type of non-Hodgkin,s lymphoma. , ... today,s issue of Cancer Cell show that an experimental ... College, the University of Maryland and the Ontario Cancer Center at ...
Cached Medicine News:Health News:ZSL Partners with Infor to Resell ERP SyteLine & Provide Industry's Most Innovative ERP Solutions 2Health News:Test May Measure Suicidal Tendencies 2Health News:Study Offers Insights Into Male Pattern Baldness 2Health News:McGraw-Hill Signs Corporate Visions Experts to Book Deal 2Health News:Classic Maya history is embedded in commoners' homes 2Health News:Classic Maya history is embedded in commoners' homes 3Health News:New class of drug kills lymphoma cells 2
... Controls are liquid controls designed ... test procedures that detect Chlamydia ... they are specimen specific, they ... urine or endocervical/urethral swabs throughout ...
Liquichek Pediatric Control is a product designed to monitor important analytes for neonatal testing. This control monitors four bilirubin parameters at two clinically significant levels....
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Liquichek Therapeutic Drug Monitoring Control (TDM) is a liquid assayed control containing a comprehensive menu of therapeutic drugs, as well as many common ligands. Available in three levels....
Medicine Products: